[go: up one dir, main page]

CH552613A - Verfahren zur herstellung von zur pharmazeutischen verwendung geeigneten heterocyclischen verbindungen. - Google Patents

Verfahren zur herstellung von zur pharmazeutischen verwendung geeigneten heterocyclischen verbindungen.

Info

Publication number
CH552613A
CH552613A CH1162970A CH1162970A CH552613A CH 552613 A CH552613 A CH 552613A CH 1162970 A CH1162970 A CH 1162970A CH 1162970 A CH1162970 A CH 1162970A CH 552613 A CH552613 A CH 552613A
Authority
CH
Switzerland
Prior art keywords
preparation
heterocyclic compounds
pharmaceutical use
compounds suitable
pharmaceutical
Prior art date
Application number
CH1162970A
Other languages
English (en)
Original Assignee
Yoshitomi Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yoshitomi Pharmaceutical filed Critical Yoshitomi Pharmaceutical
Publication of CH552613A publication Critical patent/CH552613A/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CH1162970A 1969-07-31 1970-07-31 Verfahren zur herstellung von zur pharmazeutischen verwendung geeigneten heterocyclischen verbindungen. CH552613A (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP6065169 1969-07-31
JP7677569 1969-09-25
JP7947869 1969-10-02

Publications (1)

Publication Number Publication Date
CH552613A true CH552613A (de) 1974-08-15

Family

ID=27297252

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1162970A CH552613A (de) 1969-07-31 1970-07-31 Verfahren zur herstellung von zur pharmazeutischen verwendung geeigneten heterocyclischen verbindungen.

Country Status (9)

Country Link
US (1) US3761481A (de)
AT (1) AT303738B (de)
BE (1) BE754054A (de)
CA (1) CA918659A (de)
CH (1) CH552613A (de)
DE (1) DE2038206A1 (de)
FR (1) FR2059581B1 (de)
GB (1) GB1290768A (de)
SE (1) SE366990B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1323659A (en) * 1971-04-10 1973-07-18 Yoshitomi Pharmaceutical Piperazine derivatives methods for their production and pharmaceuticl compositions containing them
FR2176528B1 (de) * 1972-03-22 1975-04-25 Roussel Uclaf
US4115568A (en) * 1974-11-26 1978-09-19 Lilly Industries Limited Thieno[3,2-b]-[1,5]benzodiazepines
GB1587128A (en) * 1977-04-07 1981-04-01 Hexachimie Benzothiazepine derivatives
FI803030A (fi) * 1979-10-01 1981-04-02 Sandoz Ag Dibensazepinderivat deras framstaellning och farmaceutiska sammansaettningar innehaollande dessa
US4404137A (en) * 1979-10-16 1983-09-13 Lilly Industries Limited Pyrazolo [3,4-b][1,5]benzodiazepine compounds
US4431589A (en) * 1980-12-11 1984-02-14 Lilly House Benzodiazepine compounds and their use as pharmaceuticals
GB8607684D0 (en) * 1986-03-27 1986-04-30 Ici America Inc Thiazepine compounds
US5602120A (en) * 1994-12-12 1997-02-11 Allelix Biopharmaceuticals, Inc. Benzyl-substituted compounds having dopamine receptor affinity
US5700445A (en) * 1994-12-12 1997-12-23 Allelix Biopharmaceuticals, Inc. N-methyl piperazine compounds having dopamine receptor affinity
BR0111976A (pt) * 2000-06-27 2003-12-09 Taisho Pharmaceutical Co Ltd Preparação terapêutica para neurose ou depressão por ansiedade, e, derivado de piperazina
KR20050092123A (ko) * 2003-01-23 2005-09-20 아카디아 파마슈티칼스 인코포레이티드 Ｎ-데스메틸클로자핀의 인간의 신경정신성 질환의 치료용도
US20050250767A1 (en) * 2003-01-23 2005-11-10 Weiner David M Use of N-desmethylclozapine to treat human neuropsychiatric disease
CN101962369A (zh) 2003-12-22 2011-02-02 阿卡蒂亚药品公司 氨基取代的二芳基[a,d]环庚烯类似物作为毒蕈碱激动剂的用途及神经精神疾病的治疗方法
KR20070007888A (ko) * 2004-04-01 2007-01-16 아카디아 파마슈티칼스 인코포레이티드 결정질 ｎ-데스메틸클로자핀
WO2007053618A1 (en) * 2005-10-31 2007-05-10 Acadia Pharmaceuticals Inc. Prodrugs of muscarinic agonists and methods of treatment of neuropsychiatric disorders
PL395468A1 (pl) * 2011-06-29 2013-01-07 Adamed Spólka Z Ograniczona Odpowiedzialnoscia Zwiazki amidoalkilopiperazynylowe do leczenia chorób osrodkowego ukladu nerwowego

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL140242B (nl) * 1963-03-01 1973-11-15 Wander Ag Dr A Werkwijze voor het bereiden van op de 11-plaats door een basische groep gesubstitueerde dibenz (b.f.)(1.4) oxazepinen.
FR4356M (de) * 1965-01-27 1966-08-16
FR1478355A (fr) * 1965-08-23 1967-04-28 Rhone Poulenc Sa Nouveaux dérivés de la dibenzothiépinne et leur préparation
GB1192812A (en) * 1966-05-20 1970-05-20 American Cyanamid Co 2-Chloro-11-(1-Piperazinyl)Dibenz[b,f]-[1,4]Oxazepine, Non-Toxic Acid Addition Salts thereof, and Therapeutic Compositions containing said Oxazepine or Salts
US3625974A (en) * 1967-04-28 1971-12-07 Fujisawa Pharmaceutical Co Dibenzothiazepine derivatives
US3705245A (en) * 1972-01-24 1972-12-05 American Cyanamid Co 7-amino - 2-chloro-11-(4-methyl-1-piperazinyl)dibenz(b,f)(1,4)oxazepines acting on the central nervous system

Also Published As

Publication number Publication date
SE366990B (de) 1974-05-13
BE754054A (fr) 1970-12-31
DE2038206A1 (de) 1971-02-25
CA918659A (en) 1973-01-09
GB1290768A (de) 1972-09-27
US3761481A (en) 1973-09-25
FR2059581B1 (de) 1974-06-14
FR2059581A1 (de) 1971-06-04
AT303738B (de) 1972-12-11

Similar Documents

Publication Publication Date Title
CH540247A (de) Verfahren zur Herstellung von heterocyclischen, Asthylendoppelbindungen enthaltenden Verbindungen
AT319239B (de) Verfahren zur Herstellung von neuen heterocyclischen Verbindungen
CH552613A (de) Verfahren zur herstellung von zur pharmazeutischen verwendung geeigneten heterocyclischen verbindungen.
CH536310A (de) Verfahren zur Herstellung von Dibenzazepin-Derivaten
CH554861A (de) Verfahren zur herstellung von (gamma)-piperidinobutyrophenonderivaten.
CH552593A (de) Verfahren zur herstellung von pyridinthioacetamidderivaten.
CH500992A (de) Verfahren zur Herstellung von pharmazeutischen Verbindungen
CH551432A (de) Verfahren zur herstellung von benzodiazepinderivaten.
CH544102A (de) Verfahren zur Herstellung von heterocyclischen Verbindungen
CH538488A (de) Verfahren zur Herstellung von heterocyclischen Verbindungen
CH552631A (de) Verfahren zur herstellung von n-acylderivaten von phosphoramidothioaten.
AT307406B (de) Verfahren zur Herstellung von neuen heterocyclischen Verbindungen
CH557349A (de) Verfahren zur herstellung von n-acylamino-pyrrolidinonderivaten.
AT317447B (de) Verfahren zur Herstellung von neuen heterocyclischen Verbindungen
CH542865A (de) Verfahren zur Herstellung von heterocyclischen Verbindungen
CH505131A (de) Verfahren zur Herstellung von heterocyklischen Verbindungen
AT300789B (de) Verfahren zur Herstellung von Nitroimidazolderivaten
AT311334B (de) Verfahren zur Herstellung von neuen heterocylischen Verbindungen
CH498858A (de) Verfahren zur Herstellung von acht Ringglieder enthaltenden heterocyclischen Verbindungen
CH557357A (de) Verfahren zur herstellung von benzodiazepinderivaten.
CH533097A (de) Verfahren zur Herstellung von neuen heterocyclischen Verbindungen
CH557831A (de) Verfahren zur herstellung von triazolobenzodiazepin-5noxydderivaten.
CH546243A (de) Verfahren zur herstellung von chinazolindion-derivaten.
CH552602A (de) Verfahren zur herstellung von n-substituierten derivaten heterocyclischer verbindungen.
CH548405A (de) Verfahren zur herstellung von benzodiazepinderivaten.

Legal Events

Date Code Title Description
PL Patent ceased